Literature DB >> 21506562

Constituents in kava extracts potentially involved in hepatotoxicity: a review.

Line R Olsen1, Mark P Grillo, Christian Skonberg.   

Abstract

Aqueous kava root preparations have been consumed in the South Pacific as an apparently safe ceremonial and cultural drink for centuries. However, several reports of hepatotoxicity have been linked to the consumption of kava extracts in Western countries, where mainly ethanolic or acetonic extracts are used. The mechanism of toxicity has not been established, although several theories have been put forward. The composition of the major constituents, the kava lactones, varies according to preparation method and species of kava plant, and thus, the toxicity of the individual lactones has been tested in order to establish whether a single lactone or a certain composition of lactones may be responsible for the increased prevalence of kava-induced hepatotoxicity in Western countries. However, no such conclusion has been made on the basis of current data. Inhibition or induction of the major metabolizing enzymes, which might result in drug interactions, has also gained attention, but ambiguous results have been reported. On the basis of the chemical structures of kava constituents, the formation of reactive metabolites has also been suggested as an explanation of toxicity. Furthermore, skin rash is a side effect in kava consumers, which may be indicative of the formation of reactive metabolites and covalent binding to skin proteins leading to immune-mediated responses. Reactive metabolites of kava lactones have been identified in vitro as glutathione (GSH) conjugates and in vivo as mercapturates excreted in urine. Addition of GSH to kava extracts has been shown to reduce cytotoxicity in vitro, which suggests the presence of inherently reactive constituents. Only a few studies have investigated the toxicity of the minor constituents present in kava extract, such as pipermethystine and the flavokavains, where some have been shown to display higher in vitro cytotoxicity than the lactones. To date, there remains no indisputable reason for the increased prevalence of kava-induced hepatotoxicity in Western countries.
© 2011 American Chemical Society

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21506562     DOI: 10.1021/tx100412m

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  14 in total

1.  Synthesis and antimalarial and antituberculosis activities of a series of natural and unnatural 4-methoxy-6-styryl-pyran-2-ones, dihydro analogues and photo-dimers.

Authors:  Stephen T McCracken; Marcel Kaiser; Helena I Boshoff; Peter D W Boyd; Brent R Copp
Journal:  Bioorg Med Chem       Date:  2012-01-02       Impact factor: 3.641

2.  Kavain Inhibition of LPS-Induced TNF-α via ERK/LITAF.

Authors:  Xiaoren Tang; Salomon Amar
Journal:  Toxicol Res (Camb)       Date:  2015-10-21       Impact factor: 3.524

3.  The Impact of One-week Dietary Supplementation with Kava on Biomarkers of Tobacco Use and Nitrosamine-based Carcinogenesis Risk among Active Smokers.

Authors:  Yi Wang; Sreekanth C Narayanapillai; Katelyn M Tessier; Lori G Strayer; Pramod Upadhyaya; Qi Hu; Rick Kingston; Ramzi G Salloum; Junxuan Lu; Stephen S Hecht; Dorothy K Hatsukami; Naomi Fujioka; Chengguo Xing
Journal:  Cancer Prev Res (Phila)       Date:  2020-02-26

4.  Flavokawains A and B from kava (Piper methysticum) activate heat shock and antioxidant responses and protect against hydrogen peroxide-induced cell death in HepG2 hepatocytes.

Authors:  Keanu D Pinner; Christina T K Wales; Rachel A Gristock; Hoa T Vo; Nadine So; Aaron T Jacobs
Journal:  Pharm Biol       Date:  2016-01-20       Impact factor: 3.503

5.  Kava hepatotoxicity in traditional and modern use: the presumed Pacific kava paradox hypothesis revisited.

Authors:  Rolf Teschke; Jerome Sarris; Isaac Schweitzer
Journal:  Br J Clin Pharmacol       Date:  2012-02       Impact factor: 4.335

6.  Methysticin and 7,8-dihydromethysticin are two major kavalactones in kava extract to induce CYP1A1.

Authors:  Yan Li; Hu Mei; Qiangen Wu; Suhui Zhang; Jia-Long Fang; Leming Shi; Lei Guo
Journal:  Toxicol Sci       Date:  2011-09-09       Impact factor: 4.849

7.  Kava-241 reduced periodontal destruction in a collagen antibody primed Porphyromonas gingivalis model of periodontitis.

Authors:  Abdulsalam Alshammari; Jayesh Patel; Jacob Al-Hashemi; Bin Cai; James Panek; Olivier Huck; Salomon Amar
Journal:  J Clin Periodontol       Date:  2017-09-21       Impact factor: 8.728

8.  Measuring the chemical and cytotoxic variability of commercially available kava (Piper methysticum G. Forster).

Authors:  Amanda C Martin; Ed Johnston; Chengguo Xing; Adrian D Hegeman
Journal:  PLoS One       Date:  2014-11-03       Impact factor: 3.240

Review 9.  Hepatotoxicity Induced by "the 3Ks": Kava, Kratom and Khat.

Authors:  Flaminia Pantano; Roberta Tittarelli; Giulio Mannocchi; Simona Zaami; Serafino Ricci; Raffaele Giorgetti; Daniela Terranova; Francesco P Busardò; Enrico Marinelli
Journal:  Int J Mol Sci       Date:  2016-04-16       Impact factor: 5.923

Review 10.  Herbal Hepatotoxicity: Clinical Characteristics and Listing Compilation.

Authors:  Christian Frenzel; Rolf Teschke
Journal:  Int J Mol Sci       Date:  2016-04-27       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.